Optoelectronic method for detection of letrozole and its metabolite in urine samples

Georgeta-Marcela Bican; Jeni-Carla Colev; Mihai Ionică

doi:10.1117/12.2323814

31 December 2018 Optoelectronic method for detection of letrozole and its metabolite in urine samples

Georgeta-Marcela Bican, Jeni-Carla Colev, Mihai Ionică

Proceedings Volume 10977, Advanced Topics in Optoelectronics, Microelectronics, and Nanotechnologies IX; 109773D (2018) https://doi.org/10.1117/12.2323814
Event: Advanced Topics in Optoelectronics, Microelectronics and Nanotechnologies IX, 2018, Constanta, Romania

Abstract

The increase in the number of cases of breast cancer required the development of new pharmaceutical formulas, letrozole being one of the drugs used for this purpose. Treatment with this drug requires detection and monitoring of these substances¹. In the doping control of athletes, letrozole is a forbidden substance. Letrozole is included in the Prohibited List of World Anti-Doping Agency (WADA) at the Sections Hormone and Metabolic modulators, Aromatase inhibitors, selective estrogen receptor modulators (SERMs) and other anti-estrogenic substances^2,3. For the analysis of these compounds, the technique of choice is the liquid-chromatography tandem mass spectrometry technique (LC-MS/MS). Due to the metabolism of the substance, it is required the analysis of both the compound and the metabolite bis-(4- cyanophenyl)methanol by LC-MS/MS. In the WADA Technical Document TD2018MRPL, the Minimum Required Performance Levels for Detection and Identification of Non-threshold Substances (MRPL) for anti-estrogenic substances is 20 ng/mL^2,4. This paper discloses the optimization of the LC-MS/MS detection parameters of letrozol and letrozol metabolite.

Citation Download Citation

Georgeta-Marcela Bican, Jeni-Carla Colev, and Mihai Ionică "Optoelectronic method for detection of letrozole and its metabolite in urine samples", Proc. SPIE 10977, Advanced Topics in Optoelectronics, Microelectronics, and Nanotechnologies IX, 109773D (31 December 2018); https://doi.org/10.1117/12.2323814

ACCESS THE FULL ARTICLE

INSTITUTIONAL
Select your institution to access the SPIE Digital Library.

SELECT YOUR INSTITUTION

PERSONAL
Sign in with your SPIE account to access your personal subscriptions or to use specific features such as save to my library, sign up for alerts, save searches, etc.

PERSONAL SIGN IN

No SPIE Account? Create one

PURCHASE THIS CONTENT

SUBSCRIBE TO DIGITAL LIBRARY

50 downloads per 1-year subscription

Members: $195

Non-members: $335 ADD TO CART

25 downloads per 1 - year subscription

Members: $145

Non-members: $250 ADD TO CART

PURCHASE SINGLE ARTICLE

Includes PDF, HTML & Video, when available